The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
| 99 |
Synthesis and structure-activity relationships of potent retinoid X receptor ligands![EBI](/images/logo_chembl.png) |
TBA |
15006411 |
126 |
Design, synthesis and structure-activity relationship of novel RXR-selective modulators.![EBI](/images/logo_chembl.png) |
Ligand Pharmaceuticals |
12482435 |
75 |
Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.![EBI](/images/logo_chembl.png) |
Ligand Pharmaceuticals |
10543887 |
12 |
Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.![EBI](/images/logo_chembl.png) |
University of Oklahoma Health Sciences Center |
10479291 |
12 |
Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.![EBI](/images/logo_chembl.png) |
University of Oklahoma Health Sciences Center |
9572893 |
64 |
Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemias.![EBI](/images/logo_chembl.png) |
University of Alabama At Birmingham |
8784454 |
76 |
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.![EBI](/images/logo_chembl.png) |
Allergan |
8071941 |
240 |
Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.![EBI](/images/logo_chembl.png) |
Ligand Pharmaceuticals |
7636877 |
96 |
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.![EBI](/images/logo_chembl.png) |
Ligand Pharmaceuticals |
7608895 |
61 |
Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activity.![EBI](/images/logo_chembl.png) |
University of Alabama At Birmingham |